Top

Published in:

01-10-2013 | Original

Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study

Authors: Marta Di Pasquale, Mariano Esperatti, Ernesto Crisafulli, Miquel Ferrer, Gianluigi Li Bassi, Mariano Rinaudo, Angels Escorsell, Javier Fernandez, Antoni Mas, Francesco Blasi, Antoni Torres

Published in: Intensive Care Medicine | Issue 10/2013

Abstract

Purpose

To assess the impact of chronic liver disease (CLD) on ICU-acquired pneumonia.

Methods

This was a prospective, observational study of the characteristics, microbiology, and outcomes of 343 consecutive patients with ICU-acquired pneumonia clustered according to the presence of CLD.

Results

Sixty-seven (20 %) patients had CLD (67 % had liver cirrhosis, LC), MELD score 26 ± 9, 20 % Child–Pugh class C). They presented higher severity scores than patients without CLD both on admission to the ICU (APACHE II, LC 19 ± 6 vs. other CLD 18 ± 6 vs. no CLD 16 ± 6; p < 0.001; SOFA, 10 ± 3 vs. 8 ± 4 vs. 7 ± 3; p < 0.001) and at onset of pneumonia (APACHE II, 19 ± 6 vs. 17 ± 6 vs. 16 ± 5; p = 0.001; SOFA, 11 ± 4 vs. 9 ± 4 vs. 7 ± 3; p < 0.001). Levels of CRP were lower in patients with LC than in the other two groups (day 1, 6.5 [2.5–11.5] vs. 13 [6–23] vs. 15.5 [8–24], p < 0.001, day 3, 6 [3–12] vs. 16 [9–21] vs. 11 [5–20], p = 0.001); all the other biomarkers were higher in LC and other CLD patients. LC patients had higher 28- and 90-day mortality (63 vs. 28 %, p < 0.001; 72 vs. 38 %, p < 0.001, respectively) than non-CLD patients. Presence of LC was independently associated with decreased 28- and 90-day survival (95 % confidence interval [CI], 1.982–17.250; p = 0.001; 95 % confidence interval [CI], 2.915–20.699, p = 0.001, respectively).

Conclusions

In critically ill patients with ICU-acquired pneumonia, CLD is associated with a more severe clinical presentation and poor clinical outcomes. Moreover, LC is independently associated with 28- and 90-day mortality. The results of this study are important for future trials focused on mortality.

Available only for authorised users

American Thoracic Society Infectious Diseases Society of America (2005) Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 171:388–416CrossRef

Chastre J, Fagon JY (2002) Ventilator-associated pneumonia. Am J Respir Crit Care Med 165:867–903PubMedCrossRef

Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo L, Zavala E, Welte T, Torres A (2013) Nosocomial pneumonia in the intensive care unit acquired during mechanical ventilation or not). Am J Respir Crit Care Med 182:1533–1539CrossRef

Fagon JY, Chastre J, Hance AJ, Montravers P, Novara A, Gilbert C (1993) Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay. Am J Med 94:281–288PubMedCrossRef

Kollef MH (2010) Review of recent clinical trials of hospital-acquired pneumonia and ventilator-associated pneumonia: a perspective from academia. Clin Infect Dis 51(Suppl 1):S29–S35PubMedCrossRef

Nseir S, Di Pompeo C, Soubrier S, Cavestri B, Jozefowicz E, Saulnier F, Durocher A (2005) Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 128:1650–1656PubMedCrossRef

Arvaniti V, D’Amico G, Fede G, Manousou P, Tsochatzis E, Pleguezuelo M, Burroughs AK (2010) Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 139(4):1246–1256PubMedCrossRef

Garcia-Tsao G (2004) Bacterial infections in cirrhosis. Can J Gastroenterol 18(6):405–406PubMed

Aggarwal A, Ong JP, Younossi ZM, Nelson DR, Hoffman-Hogg L, Arroliga AC (2001) Predictors of mortality and resource utilization in cirrhotic patients admitted to the medical ICU. Chest 119(5):1489–1497PubMedCrossRef

10.

Cheruvattah R, Balan V (2007) Infections in patients with end-stage liver disease. J Clin Gastroenterol 41(4):403–411CrossRef

11.

Fica A (2005) Diagnosis, management and prevention of infections in cirrhotic patients. Rev Chil Infect 22(1):63–74

12.

Deschenes M, Villeneuve JP (1999) Risk factors for the development of bacterial infections in hospitalized patients with cirrhosis. Am J Gastroenterol 94:2193–2197PubMed

13.

Mabee CL, Fromkes JJ, Pacht ER, Ayers LW, Kirkpatrick RB, Sundaram U (1998) Pulmonary infections in hospitalized patients with cirrhosis. J Clin Gastroenterol 26(1):44–49PubMedCrossRef

14.

Fernandez J, Acevedo J, Castro M, Garcia O, de Lope CR, Roca D, Pavesi M, Sola E, Moreira L, Silva A, Seva-Pereira T, Corradi F, Mensa J, Ginès P, Arroyo V (2012) Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: a prospective study. Hepatology 55(5):1551–1561PubMedCrossRef

15.

Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMedCrossRef

16.

Fabregas N, Ewig S, Torres A, El Ebiary M, Ramirez J, de la Bellacasa JP, Bauer T, Cabello H (1999) Clinical diagnosis of ventilator associated pneumonia revisited: comparative validation using immediate post-mortem lung biopsies. Thorax 54:867–873PubMedCrossRef

17.

Luna CM, Blanzaco D, Niederman MS, Matarucco W, Baredes NC, Desmery P, Palizas F, Menga G, Rios F, Apezteguia C (2003) Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome. Crit Care Med 31:676–682PubMedCrossRef

18.

Sandiumenge A, Rello J (2012) Ventilator-associated pneumonia caused by ESKAPE organisms: cause, clinical features, and management. Curr Opin Pulm Med 18:187–193PubMedCrossRef

19.

Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II a severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRef

20.

Le Gall JR, Lemeshow S, Saulnier F (1993) A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270(24):2957–2963PubMedCrossRef

21.

Vincent JL, Moreno R, Takala J, Willatts S, De Mendonça A, Bruining H, Reinhart CK, Suter PM, Thijs LG (1996) The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Int Care Med 22:707–710CrossRef

22.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL (2008) Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 36:296–327PubMedCrossRef

23.

Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824PubMedCrossRef

24.

Ramirez P, Ferrer M, Marti V, Reyes S, Martinez R, Menendez R, Ewig S, Torres A (2011) Inflammatory biomarkers and prediction for intensive care unit admission in severe community-acquired pneumonia. Crit Care Med 39:2211–2217PubMedCrossRef

25.

Ioanas M, Ferrer M, Cavalcanti M, Ferrer R, Ewig S, Filella X, de la Bellacasa JP, Torres A (2004) Causes and predictors of non-response to treatment of the ICU-acquired pneumonia. Crit Care Med 32:938–945PubMedCrossRef

26.

Caly WR, Strauss E (1993) A prospective study of bacterial infections in patients with cirrhosis. J Hepatol 18:353–358PubMedCrossRef

27.

Tandon P, Garcia-Tsao G (2008) Bacterial infections, sepsis, and multiorgan failure in cirrhosis. Semin Liver Dis 28:26–42PubMedCrossRef

28.

Wehler M, Kokoska J, Reulbach U, Hahn EG, Strauss R (2001) Short-term prognosis in critically ill patients with cirrhosis assessed by prognostic scoring systems. Hepatology 34(2):255–261PubMedCrossRef

29.

Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodés J (2002) Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 35:140–148PubMedCrossRef

30.

Lynch J (2001) Hospital-acquired pneumonia: risk factors, microbiology and treatment. Chest 119:373S–384SPubMedCrossRef

31.

Jones RN (2010) Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Clin Infect Dis 51(S1):S81–S87PubMedCrossRef

32.

Kohlenberg A, Schwab F, Behnke M, Geffers C, Gastmeier P (2010) Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med 36:971–978PubMedCrossRef

33.

Calabro P, Willerson JT, Yeh ET (2003) Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. Circulation 108:1930–1932PubMedCrossRef

34.

Yasojima K, Schwab C, McGeer EG, McGeer PL (2000) Human neurons generate C-reactive protein and amyloid P: upregulation in Alzheimer’s disease. Brain Res 887:80–89PubMedCrossRef

35.

Huang D, Angus DC, Kellum JA, Pugh NA, Weissfeld LA, Struck J, Delude RL, Rosengart MR, Yealy DM (2009) Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia. Chest 136:823–831PubMedCrossRef

36.

Weinhold B, Ruther U (1997) Interleukin-6-dependent and independent regulation of the human C-reactive protein gene. Biochem J 327:425–429PubMed

37.

Harden L (2013) Interleukin-10 modulates the synthesis of inflammatory mediators in the sensory circumventricular organs: implications for the regulation of fever and sickness behaviors. J Neuroinflammat 10:22CrossRef

38.

Bota DP, Van Nuffelen M, Zakariah AN, Vincent J (2005) Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver. J Lab Clin Med 146(6):347–351PubMedCrossRef

39.

Rosa H, Silvério AO, Perini RF, Arruda CB (2000) Bacterial infections in cirrhotic patients and its relationship with alcohol. Am J Gastroenterol 95(5):1290–1293PubMedCrossRef

Title: Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study
Authors: Marta Di Pasquale
Mariano Esperatti
Ernesto Crisafulli
Miquel Ferrer
Gianluigi Li Bassi
Mariano Rinaudo
Angels Escorsell
Javier Fernandez
Antoni Mas
Francesco Blasi
Antoni Torres
Publication date: 01-10-2013
Publisher: Springer Berlin Heidelberg
Published in: Intensive Care Medicine / Issue 10/2013
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI: https://doi.org/10.1007/s00134-013-3025-6

At a glance: The STEP trials

Springer Medicine

Impact of chronic liver disease in intensive care unit acquired pneumonia: a prospective study

Abstract

Purpose

Methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 10/2013

Endothelial protein C receptor polymorphisms and risk of severe sepsis in critically ill patients

What’s new on the post-ICU burden for patients and relatives?

Critical research on biomarkers: what’s new?

Quality improvement of interdisciplinary rounds by leadership training based on essential quality indicators of the Interdisciplinary Rounds Assessment Scale

Looking beyond survival rates: neurological outcomes after extracorporeal life support

Highlighting the important effect of systemic lupus erythematosus on platelet count of critically ill patients